L. Spivak

Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial

A. Vinarov, D. Pushkar, M. Putilovskiy, 2018, Central European journal of urology.

[Treatment of chronic prostatitis in prophylaxis of prostatic adenoma].

A. Vinarov, L. Spivak, I. G. Aliaev, 2012, Urologiia.

15 years’ survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression

A. Vinarov, L. Rapoport, D. Korolev, 2019, Urologia.